These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38108065)

  • 21. DHFR silence alleviated the development of liver fibrosis by affecting the crosstalk between hepatic stellate cells and macrophages.
    Peng Y; Li Z; Chen S; Zhou J
    J Cell Mol Med; 2021 Nov; 25(21):10049-10060. PubMed ID: 34626074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress of extracellular vesicles in hepatic fibrosis].
    Tao CY; Guo JS; Shi YH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):407-410. PubMed ID: 31357753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis.
    Chiabotto G; Pasquino C; Camussi G; Bruno S
    Front Cell Dev Biol; 2020; 8():594794. PubMed ID: 33425900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update.
    Zheng Y; Xie L; Yang D; Luo K; Li X
    Phytomedicine; 2023 May; 113():154721. PubMed ID: 36870824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis.
    Garbuzenko DV
    World J Clin Cases; 2022 Apr; 10(12):3662-3676. PubMed ID: 35647163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
    Khanam A; Saleeb PG; Kottilil S
    Cells; 2021 May; 10(5):. PubMed ID: 34064375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.
    Wang L; Wang Y; Quan J
    Hum Cell; 2020 Jul; 33(3):582-589. PubMed ID: 32449114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal miR-181a-2-3p derived from citreoviridin-treated hepatocytes activates hepatic stellate cells trough inducing mitochondrial calcium overload.
    Dong Z; Yang X; Qiu T; An Y; Zhang G; Li Q; Jiang L; Yang G; Cao J; Sun X; Liu X; Liu D; Yao X
    Chem Biol Interact; 2022 May; 358():109899. PubMed ID: 35305974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype.
    Chiabotto G; Ceccotti E; Tapparo M; Camussi G; Bruno S
    Front Cell Dev Biol; 2021; 9():777462. PubMed ID: 34796180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies.
    Rahman MA; Patters BJ; Kodidela S; Kumar S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):409-421. PubMed ID: 30955131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease.
    Luo X; Luo SZ; Xu ZX; Zhou C; Li ZH; Zhou XY; Xu MY
    World J Gastroenterol; 2021 Apr; 27(14):1419-1434. PubMed ID: 33911465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights.
    Greuter T; Shah VH
    J Gastroenterol; 2016 Jun; 51(6):511-9. PubMed ID: 26939970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells.
    Safran M; Masoud R; Sultan M; Tachlytski I; Chai Gadot C; Pery R; Balint-Lahat N; Pappo O; Buzaglo N; Ben-Ari Z
    Cells; 2022 May; 11(10):. PubMed ID: 35626751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.
    Cai X; Wang J; Wang J; Zhou Q; Yang B; He Q; Weng Q
    Pharmacol Res; 2020 May; 155():104720. PubMed ID: 32092405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2.
    Chen L; Huang Y; Duan Z; Huang P; Yao H; Zhou Y; Ji Q; Liu X
    Front Cell Dev Biol; 2021; 9():716209. PubMed ID: 34676206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes as mediators and biomarkers in fibrosis.
    Qin XJ; Zhang JX; Wang RL
    Biomark Med; 2020 Jun; 14(8):697-712. PubMed ID: 32643390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells.
    Zhou X; Liang Z; Qin S; Ruan X; Jiang H
    Mol Biol Rep; 2022 Mar; 49(3):1945-1954. PubMed ID: 34843038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.
    Wan L; Xia T; Du Y; Liu J; Xie Y; Zhang Y; Guan F; Wu J; Wang X; Shi C
    FASEB J; 2019 Jul; 33(7):8530-8542. PubMed ID: 30970216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.